Bionano Genomics, Inc. Common Stock

$1.175
USD
Last updated on --.
24h volume207.51K
24h highest1.3040 USD
24h lowest1.1700 USD
24h Price movement+0.43%

BNGO recent prices

24 Hours
+0.43%+$0.005
30 days
-8.91%-$0.115
60 days
-0.42%-$0.005
90 days
+4.91%+$0.055

Key data

Previous close1.1700 USD
Market cap14.23M USD
Volume207.51K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.7500 USD
Net income (FY)-31.60M USD
Revenue (FY)28.74M USD
Last report dateMay 13, 2026

About Bionano Genomics, Inc. Common Stock

LABORATORY ANALYTICAL INSTRUMENTS
HeadquartersSAN DIEGO
Employees (FY)97.00
Revenue per employee (FY)296.27K USD
Net income per employee (FY)-325.73K USD
Listed onNasdaq
Official website

BNGO conversion tables

BNGOBNGO
USDUSD
0.5 BNGO0.5875 USD
1 BNGO1.175 USD
5 BNGO5.875 USD
10 BNGO11.75 USD
USDUSD
BNGOBNGO
0.5 USD0.42553 BNGO
1 USD0.85106 BNGO
5 USD4.255 BNGO
10 USD8.510 BNGO

FAQ

BNGO is trading at $1.175, +0.43% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BNGO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BNGO is currently trading at $1.175, +0.43% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BNGO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the LABORATORY ANALYTICAL INSTRUMENTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BNGO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BNGO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BNGO's historical range and other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector.
Bionano Genomics, Inc. Common Stock's market cap is currently 14.23M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume207.51K
24h highest1.3040 USD
24h lowest1.1700 USD
24h Price movement+0.43%
BNGOBNGO
USDUSD
Start trade with BNGO Perpetual